NCT00286377View on ClinicalTrials.gov

Safety and Efficacy Study of Prosaptide to Treat Neuropathic Pain in HIV-Positive Patients

PHASE2TerminatedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

September 30, 2003

Study Completion Date

December 31, 2004

Conditions
HIVPeripheral Nervous System Disorders
Interventions
DRUG

prosaptide

Sponsors
All Listed Sponsors
collaborator

Neurologic AIDS Research Consortium (NARC)

OTHER

lead

Savient Pharmaceuticals

INDUSTRY